Asheville, NC (May 11, 2017) – Avadim Technologies Inc. (“Avadim”), the Bionome TherapiesTM life sciences company, announced today that it has executed a direct to consumer commerce services agreement with OceanX, LLC., the leading platform for the New Membership Economy powering some of the most recognizable brands in subscriptions via its integrated subscription platform.
The agreement provides for a new direct-to-consumer subscription sales channel comprised of subscription e-commerce, order processing and management, credit card and payment processing, customized fulfillment, customer care, returns handling, business intelligence and related services for direct to consumer commerce.
“We are pleased to have partnered with OceanX, a company that has a technology platform that focuses on physical subscriptions,” said Steve Woody, Chairman and CEO of Avadim. “While we continue with our direct sales model for hospitals and long-term care with our sales representatives, OceanX will assist us with establishing a direct selling channel through subscriptions for our break-through bionome-engineered therapies that are changing lives for a lifetime.”
“Avadim Technologies is ahead of the curve as they invest in new ways to connect directly with their consumers,” Georg Richter, CEO & Founder of OceanX, stated. “We look forward to partnering with Avadim by using our platform, expertise, and experience to help them launch and grow in the New Membership Economy.”

About OceanX, LLC:
OceanX is leading the New Membership Economy by combining technology, services and people, to deliver subscription and membership programs everyone wants to join. The OceanX Subscription commerce platform combines subscription focused e-commerce, fulfillment, customer care and business intelligence to help brands build large-scale subscription programs that build lifelong relationships with their customers. Headquartered in Silicon Beach, OceanX, a spin-off of Guthy-Renker, is the engine that powers the New Membership Economy.

About Avadim Technologies Inc.:
Based in Asheville, North Carolina, Avadim is the Bionome TherapiesTM life sciences company. Avadim has created a new health order by eradicating the existing “sick care” approach to deliver true “health care” through topical Bionome TherapiesTM engineered to restore the skin’s natural ecosystem – each with the potential to dramatically enhance the quality of life for a lifetime. People are accepting of today’s standard of care (get sick, treat & repeat) even though it’s inadequate and few companies have stepped up to challenge this simply unacceptable approach that has been in existence for decades. Avadim is the industry leader in delivering true microbiome compliance with effective outcomes. Microbiome compliance ensures the therapy does not negatively effect the colonization of the skin’s microorganisms that human beings depend on to stay alive.

Avadim Technologies Inc. Contacts:
David Fann, President
828.251.7111 Office
904.251.4910 Cell
[email protected]

Joe McGuire, Chief Financial Officer
828.251.7111 Office
904.228.2603 Cell
[email protected]

Avadim Technologies Inc.
81 Thompson Street
Asheville, NC 28803

OceanX Contact:
Jeff Miller
Director of Marketing
[email protected]

Westbury Group Contacts:
Patrick Huddie
[email protected]
T: 443.538.4865

John Jensen
Managing Director
[email protected]
O: 203.267.0268
M: 203.615.1328

James Whitcomb
Managing Director
[email protected]
O: 203.571.3214
M: 917.881.2707

Investor Relations:
KCSA Strategic Communications
Valter Pinto
[email protected]

Media Contact:
Meghan Orencole
Kel & Partners
[email protected]
O: 617.904.9393, ext. 143
C: 857.753.3688